Pancreatic Cancer Research

ResearcherThe University of SydneyActive in the last 2 years

Ken‐Tye Yong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7936-2941; OpenAlex author ID A5083481923. Sources: OpenAlex.

Their work

Papers
14 (first author 1, last author 9)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2011: 2 papers · 2012: none · 2013: none · 2014: 2 papers · 2015: 3 papers · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 14

  1. Erratum: Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy: Erratum. Last author DOI 10.7150/ntno.105822↗
  2. Synthetic Conjugated Oligoelectrolytes Are Effective siRNA Transfection Carriers: Relevance to Pancreatic Cancer Gene Therapy. Co-author DOI 10.1021/acs.biomac.1c01498↗
  3. Carbon Dioxide-Derived Biodegradable and Cationic Polycarbonates as a New siRNA Carrier for Gene Therapy in Pancreatic Cancer. Co-author DOI 10.3390/nano11092312↗
  4. Biodegradable Polymer-Coated Multifunctional Graphene Quantum Dots for Light-Triggered Synergetic Therapy of Pancreatic Cancer. Last author DOI 10.1021/acsami.8b16168↗
  5. Functionalized MoS2 Nanosheets as Multi-Gene Delivery Vehicles for In Vivo Pancreatic Cancer Therapy. Last author DOI 10.7150/ntno.27308↗
  6. Biodegradable nanoparticles as siRNA carriers for in vivo gene silencing and pancreatic cancer therapy. Last author DOI 10.1039/c6tb03116a↗
  7. SiRNA Delivery with PEGylated Graphene Oxide Nanosheets for Combined Photothermal and Genetherapy for Pancreatic Cancer. Co-author DOI 10.7150/thno.17841↗
  8. Biodegradable nanoparticle-mediated K-ras down regulation for pancreatic cancer gene therapy. Last author DOI 10.1039/c4tb01623h↗
  9. RNAi-based therapeutic nanostrategy: IL-8 gene silencing in pancreatic cancer cells using gold nanorods delivery vehicles. Last author DOI 10.1088/0957-4484/26/36/365101↗
  10. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA. Last author DOI 10.7150/thno.11335↗
  11. Interleukin-8 gene silencing on pancreatic cancer cells using biodegradable polymer nanoplexes. Last author DOI 10.1039/c3bm60325c↗
  12. Pancreatic cancer gene therapy using an siRNA-functionalized single walled carbon nanotubes (SWNTs) nanoplex. Last author DOI 10.1039/c4bm00019f↗
  13. Anti-claudin-4-conjugated highly luminescent nanoparticles as biological labels for pancreatic cancer sensing. Co-author DOI 10.1007/978-1-61779-185-7_30↗
  14. WITHDRAWN: Synthesis and Characterization of Anticancer Drug and Antibody conjugated Quantum Dots as A Novel Theranostic Probe for Pancreatic Cancer Detection … First author DOI 10.1016/j.ejps.2011.06.016↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chengbin Yang · 9 shared papers, 2014–2022 · strength 0.64
  2. Feng Yin · 6 shared papers, 2015–2024 · strength 0.53
  3. Tommy Anderson · 5 shared papers, 2014–2024 · strength 0.44
  4. Nishtha Panwar · 3 shared papers, 2015–2024 · strength 0.36
  5. Guimiao Lin · 5 shared papers, 2014–2019 · strength 0.27
  6. Guillermo Carlos Bazan · 1 shared paper, 2022 · strength 0.15
  7. Xiang Li · 1 shared paper, 2021 · strength 0.11
  8. Xinmeng Zhang · 1 shared paper, 2021 · strength 0.11
  9. Zigang Li · 1 shared paper, 2017 · strength 0.07
  10. Paras N. Prasad · 1 shared paper, 2011 · strength 0.03
  11. Hong Yan Ding · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.